Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Supposed Help Against Tumors - How Tumor Cells Use the Body's Protection

05.12.2008
Glioblastoma is one of the most common but also most aggressive brain tumors, almost invariably leading to death in a short time. It consists of different cell types and their precursors, complicating successful treatment.

To fight the driving force of the tumor - the tumor stem cells - scientists have been trying to initiate apoptosis in these cells. However, Dr. Ana Martin-Villalba (German Cancer Research Center, DKFZ, Heidelberg, Germany) suspects that the activated apoptosis program accelerates the progress of the disease. "The tumor growth declines when apoptosis is blocked," she reported at the conference "Brain Tumor 2008" at the Max Delbrück Center (MDC) Berlin-Buch, Germany.

Glioblastomas grow like corals and form filigran branches into nearby, healthy brain tissue. For that reason it is very difficult for neurosurgeons to remove the tumor entirely because the risk of damaging healthy tissue is too high. Moreover, glioblastomas are resistant to conventional therapies which normally activate the body's apoptosis program.

This programmed cell death is a vital process. It plays an important role during development but also in the adult organism. Together with its partner CD95L, the molecular switch CD95 ensures that sick or abnormal cells are removed. Once activated, CD95 triggers a chain of different signals which in the end lead to the death of the damaged cell. Until recently, scientists were convinced that triggering apoptosis in brain tumors was a useful tool for not only killing the tumor but also the cells of its origin - the tumor stem cells.

The scientist from Heidelberg could show that CD95 as well as its partner CD95L is active in the tumor cells. However, the cells do not die. "Instead, the signal stimulates the tumor cells to migrate into neighboring, healthy brain regions," Dr. Martin-Villalba explained. For instance, it activates the protein MMP which "drills" its way into the brain tissue. "Contrary to our expectations," the neuroscientist said, "what we find when we activate apoptosis in the tumor cells is that we help them spread into healthy nerve tissue."

In experiments with mice, the researchers could already show that the tumor proliferates less aggressively when they block CD95L with an antibody, thus inhibiting the activation of programmed cell death. "With this changed perspective, we hope to develop new ideas for tumor therapy in the future," Dr. Martin-Villalba said.

Altogether, about 180 scientists and clinicians from Europe and the USA came to the two-day conference, which ended this Friday afternoon. The organizers were the MDC, the Charité - Universitätsmedizin Berlin, and HELIOS Kliniken GmbH, Berlin, a private clinic in Berlin-Buch.

Barbara Bachtler
Press and Public Affairs
Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch
Robert-Rössle-Straße 10; 13125 Berlin; Germany
Phone: +49 (0) 30 94 06 - 38 96
Fax: +49 (0) 30 94 06 - 38 33
e-mail: presse@mdc-berlin.de

Barbara Bachtler | idw
Further information:
http://www.mdc-berlin.de/
http://www.dkfz-heidelberg.de/en/molekulare-neurobiologie/index.html
http://www.cell.com/cancer-cell/retrieve/pii/S1535610808000433

More articles from Life Sciences:

nachricht Cryo-electron microscopy achieves unprecedented resolution using new computational methods
24.03.2017 | DOE/Lawrence Berkeley National Laboratory

nachricht How cheetahs stay fit and healthy
24.03.2017 | Forschungsverbund Berlin e.V.

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>